Terms: = Lung cancer AND MITF, WS2A, ENSG00000187098, 4286
56 results:
1. Transcription Factor mitf Inhibits the Transcription of CPT1B to Regulate Fatty Acid β-Oxidation and Thus Affects Stemness in lung Adenocarcinoma Cells.
Tang W; Tang H; Xu S; Yu H; Chen Z
Pharmacology; 2024; 109(1):52-64. PubMed ID: 38016436
[TBL] [Abstract] [Full Text] [Related]
2. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
3. Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells.
Lee A; Park H; Lim S; Lim J; Koh J; Jeon YK; Yang Y; Lee MS; Lim JS
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36627143
[TBL] [Abstract] [Full Text] [Related]
4. Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
[TBL] [Abstract] [Full Text] [Related]
5. CD44+ and CD133+ Non-Small Cell lung cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant cancer Cell Enrichment Relating to Their p53 Status.
Pustovalova M; Blokhina T; Alhaddad L; Chigasova A; Chuprov-Netochin R; Veviorskiy A; Filkov G; Osipov AN; Leonov S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563313
[TBL] [Abstract] [Full Text] [Related]
6. HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.
Biondini M; Kiepas A; El-Houjeiri L; Annis MG; Hsu BE; Fortier AM; Morin G; Martina JA; Sirois I; Aguilar-Mahecha A; Gruosso T; McGuirk S; Rose AAN; Tokat UM; Johnson RM; Sahin O; Bareke E; St-Pierre J; Park M; Basik M; Majewski J; Puertollano R; Pause A; Huang S; Keler T; Siegel PM
Oncogene; 2022 Mar; 41(12):1701-1717. PubMed ID: 35110681
[TBL] [Abstract] [Full Text] [Related]
7. NRF2 Enables EGFR Signaling in Melanoma Cells.
Kreß JKC; Jessen C; Marquardt A; Hufnagel A; Meierjohann S
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916908
[TBL] [Abstract] [Full Text] [Related]
8. Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis.
Tan S; Zhao Z; Qiao Y; Zhang B; Zhang T; Zhang M; Qi J; Wang X; Meng M; Zhou Q
Biochem Pharmacol; 2021 Mar; 185():114423. PubMed ID: 33476574
[TBL] [Abstract] [Full Text] [Related]
9. STAT3 promotes melanoma metastasis by CEBP-induced repression of the mitf pathway.
Swoboda A; Soukup R; Eckel O; Kinslechner K; Wingelhofer B; Schörghofer D; Sternberg C; Pham HTT; Vallianou M; Horvath J; Stoiber D; Kenner L; Larue L; Poli V; Beermann F; Yokota T; Kubicek S; Krausgruber T; Rendeiro AF; Bock C; Zenz R; Kovacic B; Aberger F; Hengstschläger M; Petzelbauer P; Mikula M; Moriggl R
Oncogene; 2021 Feb; 40(6):1091-1105. PubMed ID: 33323974
[TBL] [Abstract] [Full Text] [Related]
10. mitf functions as a tumor suppressor in non-small cell lung cancer beyond the canonically oncogenic role.
Hsiao YJ; Chang WH; Chen HY; Hsu YC; Chiu SC; Chiang CC; Chang GC; Chen YJ; Wang CY; Chen YM; Lin CY; Chen YJ; Yang PC; Chen JJW; Yu SL
Aging (Albany NY); 2020 Dec; 13(1):646-674. PubMed ID: 33293474
[TBL] [Abstract] [Full Text] [Related]
11. RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin Signaling.
Sarma A; Gajan A; Kim S; Gurdziel K; Mao G; Nangia-Makker P; Shekhar MPV
Am J Pathol; 2021 Feb; 191(2):368-384. PubMed ID: 33181138
[TBL] [Abstract] [Full Text] [Related]
12. The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.
Jessen C; Kreß JKC; Baluapuri A; Hufnagel A; Schmitz W; Kneitz S; Roth S; Marquardt A; Appenzeller S; Ade CP; Glutsch V; Wobser M; Friedmann-Angeli JP; Mosteo L; Goding CR; Schilling B; Geissinger E; Wolf E; Meierjohann S
Oncogene; 2020 Oct; 39(44):6841-6855. PubMed ID: 32978520
[TBL] [Abstract] [Full Text] [Related]
13. Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer.
Kagimoto A; Tsutani Y; Izaki Y; Handa Y; Mimae T; Miyata Y; Okada M
Jpn J Clin Oncol; 2020 Apr; 50(4):440-445. PubMed ID: 32115630
[TBL] [Abstract] [Full Text] [Related]
14. cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway.
Rathore M; Girard C; Ohanna M; Tichet M; Ben Jouira R; Garcia E; Larbret F; Gesson M; Audebert S; Lacour JP; Montaudié H; Prod'Homme V; Tartare-Deckert S; Deckert M
Oncogene; 2019 Jul; 38(30):5873-5889. PubMed ID: 31253871
[TBL] [Abstract] [Full Text] [Related]
15. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.
Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z
Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594
[TBL] [Abstract] [Full Text] [Related]
17. MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of mitf.
Pradhan AK; Bhoopathi P; Talukdar S; Scheunemann D; Sarkar D; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5687-5692. PubMed ID: 30842276
[TBL] [Abstract] [Full Text] [Related]
18. Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
Potjer TP; Bollen S; Grimbergen AJEM; van Doorn R; Gruis NA; van Asperen CJ; Hes FJ; van der Stoep N;
Int J Cancer; 2019 May; 144(10):2453-2464. PubMed ID: 30414346
[TBL] [Abstract] [Full Text] [Related]
19. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
Ruiz J; Miller AA; Tooze JA; Crane S; Petty WJ; Gajra A; Klepin HD
J Geriatr Oncol; 2019 Jan; 10(1):48-54. PubMed ID: 30005982
[TBL] [Abstract] [Full Text] [Related]
20. Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).
Katoh M
Int J Mol Med; 2018 Aug; 42(2):713-725. PubMed ID: 29786110
[TBL] [Abstract] [Full Text] [Related]
[Next]
